Navigation Links
BioVascular Inc. Closes $10.87 Million Series C Financing
Date:2/7/2008

Funds to Finance On-going Clinical Development of Saratin and BVI-007

SAN DIEGO, Feb. 7 /PRNewswire/ -- BioVascular Inc., a company focused on developing therapies targeting platelet-mediated diseases, today announced that it secured $10.87 Million in Series C financing. The Series C funds will support the clinical development of BioVascular's therapeutics targeting platelet-mediated diseases, saratin and BVI-007.

BB Biotech Ventures of Zurich, Switzerland led the financing; previous investors Merck KGaA and Domain Associates also joined the round. In connection with the financing, Martin Munchbach, Ph.D., partner of BB Biotech will join BioVascular's board of directors.

Dr. Munchbach joined BB Biotech Ventures in 2004. Prior to joining BB Biotech, he served as a partner at BioMedinvest and has held senior level positions at HBM Partners and New Medical Technologies (NMT). Before NMT, Dr. Munchbach gained experience in strategic marketing at Sanofi-Synthelabo. Dr. Munchbach holds a Ph.D. in protein chemistry, an MSc in biochemistry and a master in economics from the Swiss Federal Institute of Technology (ETH), Zurich.

"With the support of Domain Associates and Merck KGaA, BioVascular has built a solid strategy for advancing our two clinical candidates," noted John Parrish, CEO of BioVascular. "As we execute on our plan to become a world-class cardiovascular specialty therapeutics company, we welcome the financial support and advice of Dr. Munchbach and BB Biotech."

Funds raised through this financing will allow BioVascular to complete ongoing clinical trials of its two compounds, saratin and BVI-007. The company has raised a total of $18.87 million to date. Saratin is under investigation to reduce the failure of vascular grafts due to intimal hyperplasia and is currently the subject of two Phase I/II clinical trials. BVI-007, a compound that acts to reduce platelet production without affecting platelet function, is being stud
'/>"/>

SOURCE BioVascular Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
2. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
3. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
4. 10 Million Square Feet of Turf Set to be Treated in 2008 in Response to MRSA Outbreaks Nationwide
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
7. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
8. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
9. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
10. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
11. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker...s available in its catalogue: ,, HPLC Systems ...http://www.reportlinker.com/p0164366/HPLC-Systems-...ver the years, Liquid Chromatography has emerged a...euticals, food and beverage, research and developm...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, Molecular Diag....reportlinker.com/p0164231/Molecular-Diagnostics--...ostics market is being driven by several growth fa...-to-handle techniques, which combine optimized sam...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, Contract Resea...Trends & Opportunities ,, http://www.repo...g-CRO---A-Global-Update-of-Market-Trends--Opportun...RO), which came into being in the seventies, evolv...
Breaking Medicine Technology:Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Cosmetic Surgery Pioneer Goes Under the Knife 48821 1Cosmetic Surgery Pioneer Goes Under the Knife 48821 2Cosmetic Surgery Pioneer Goes Under the Knife 48821 3Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 1Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 2Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 3Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 4
...RE)--May 29, 2007 - Introgen,Therapeutics, Inc. (N...rs will report updated Phase 2 clinical trial resu... at the upcoming,annual meetings of The American S...the American Society of Gene Therapy (ASGT) in,Sea...peline of,first-in-class cancer therapies generati...
...007 /PRNewswire/ -- D-Pharm announced,today that t...tective compound DP-b99 in the treatment of acute ...European Stroke,Conference. The data will be prese...Prof. H. C. Diener, on Thursday May 31st at,14.30 ...ference,Center in Glasgow. The abstract for the pr...
Other Medicine Technology:Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3
(Date:12/2/2009)... MyCareTeam, Inc., a leading vendor ...are, has released the newest version of its softwa...nsion, congestive heart failure and weight managem...tes monitoring features. , ...eam, Inc., a leading vendor of Internet-based chro...
(Date:12/2/2009)... , American Red Cross also part of the Hewle... WASHINGTON, Dec. 2 The...d more than $1 million this year to help fund Amer...ttp://www.newscom.com/cgi-bin/prnh/20090108/RedCro..., was given to help Philippine communities affecte...
(Date:12/2/2009)..., MORRISTOWN, N.J., Dec. 2 /PRNewswire-FirstCall/...day announced that it has completed the acquisitio...ck. The purchase creates a financially strong, glo...billion in annual revenues and operations in more ...ficant benefits to Watson shareholders as a result...
(Date:12/2/2009)... Educational online events to focus ...ations. , Denver, CO (PRW...ms (FHS Corp) announced today the launch of a webi...nd patient estimations for revenue cycle, finance ...l event will occur on Tuesday, December 8, 2009 at...
(Date:12/2/2009)... Experts outline practical approach ...ance processes to build business value and reduce ...PRWEB) December 2, 2009 —- The pressure to c...ater for IT professionals than it is today. More t...wo or more regulations and corresponding audits.&s...
Breaking Medicine News(10 mins):Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:FHS Corp Announces Price Transparency Webinar Series 2Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 2Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 3
...orlds leading causes of blindness in an oven clean... used to polish glass and remove grease could be u...University of Central Florida scientists report in...nhibits carbonic anhydrase II enzyme, but also ten...
...oreign medical schools, including those from India...ore starting next year, the health ministry said S...untries like the Philippines, India and Myanmar, h...is to ease the shortage of physicians. The...
...ate the deadly poliomyelitis virus within two year...Conference (OIC) member states, Afghan Health Min... About 7.4 million children in Afghanistan needed...e might cause harm, said Muhammed Amin on the KL-O...
...c kidney disease are independently associated with...heart disease is associated with a decline in kidn... according to two reports in the issue of Archives...formation in the articles. Chronic kidney disease ...
...lready but they plan to add to their family in a b...on Stewart inquired as to just how many kids Angel... replied that she wanted to have as many as 14 lit...I'll tell you this: I admire that, because two is ...
...she became HIV infected. Six years later, she is f... and teaching them how to live with the disease . ...last three years, 27-year-old Hina from Davangere ... organised a four day National Conclave of Margina...
Other Medicine News:Health News:Studies Identify Interactions Between Heart Disease, Kidney Disease 2Health News:AIDS Patient Helps Others Lead a Positive Life 2
... System provides physicians,with an endovascular...tient body temperature, precisely,maintain a cho...rmothermic levels. ,The Celsius Control System c... proprietary disposables.,The distal portion of ...
...l system of the Applied Fiberoptics headlight deli...tion. There are six models to choose from, with bo...es from 15 mm to 120 mm., ,Each Applied Fibero...ur quality fiberoptic cables and lightsources. Eac...
...ff pump" coronary artery surgery is the latest rev...being embraced world-wide by increasing numbers of...educed mortality, stroke, and bleeding as well as ... cardiac stabilizer is mandatory for this surgery,...
... the patented Orion incorporates superior optics i... brilliantly. The fully adjustable headband, made...the brow, directing the spot along your line of vi...e diagonally over the head, balancing the headligh...
Medicine Products: